1. Home
  2. CHCO vs EVO Comparison

CHCO vs EVO Comparison

Compare CHCO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHCO
  • EVO
  • Stock Information
  • Founded
  • CHCO 1957
  • EVO 1993
  • Country
  • CHCO United States
  • EVO Germany
  • Employees
  • CHCO N/A
  • EVO N/A
  • Industry
  • CHCO Major Banks
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHCO Finance
  • EVO Health Care
  • Exchange
  • CHCO Nasdaq
  • EVO Nasdaq
  • Market Cap
  • CHCO 1.7B
  • EVO 1.5B
  • IPO Year
  • CHCO N/A
  • EVO 2021
  • Fundamental
  • Price
  • CHCO $125.30
  • EVO $4.07
  • Analyst Decision
  • CHCO Hold
  • EVO Buy
  • Analyst Count
  • CHCO 2
  • EVO 2
  • Target Price
  • CHCO $127.50
  • EVO $5.90
  • AVG Volume (30 Days)
  • CHCO 141.9K
  • EVO 112.1K
  • Earning Date
  • CHCO 07-22-2025
  • EVO 08-13-2025
  • Dividend Yield
  • CHCO 2.53%
  • EVO N/A
  • EPS Growth
  • CHCO 0.39
  • EVO N/A
  • EPS
  • CHCO 7.98
  • EVO N/A
  • Revenue
  • CHCO $293,748,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • CHCO $6.69
  • EVO $10.08
  • Revenue Next Year
  • CHCO $1.78
  • EVO $10.99
  • P/E Ratio
  • CHCO $15.66
  • EVO N/A
  • Revenue Growth
  • CHCO 1.31
  • EVO 1.50
  • 52 Week Low
  • CHCO $102.22
  • EVO $2.84
  • 52 Week High
  • CHCO $137.28
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • CHCO 58.24
  • EVO 47.66
  • Support Level
  • CHCO $124.85
  • EVO $4.12
  • Resistance Level
  • CHCO $129.93
  • EVO $4.26
  • Average True Range (ATR)
  • CHCO 2.77
  • EVO 0.11
  • MACD
  • CHCO 0.29
  • EVO -0.01
  • Stochastic Oscillator
  • CHCO 62.56
  • EVO 54.84

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: